Characteristics of carcass and non-carcass components of lambs fed diets containing silages of forages adapted to the semi-arid environment

The aim of this study was to evaluate the effects of diets containing silages of forages that are adapted to the semi-arid environment on the characteristics of the carcass and of non-carcass components of 32 mixed-breed lambs at approximately six months old, with an average live weight of 17.61 ± 2.63 kg. Lambs were assigned to four treatments (diets containing silages of Atriplex nummularia Lind, Cenchrus ciliaris, Gliricidia sepium and Manihot sp.) in a completely randomized design with eight replicates. Animals fed the diet containing old man saltbush showed higher values for the intakes of dry matter (1.080 g/day), crude protein (190 g/day) and total digestible nutrients (740 g/day), body condition score (2.81 points), fatness (2.87 points), carcass conformation (3.19 points), live weight (29.1 kg), empty bodyweight (23.41 kg), weights of the commercial cuts neck, shoulder and ribs (0.46, 0.82 and 1.12 kg, respectively), and skin weight (1.972 kg). No differences were found between the diets for carcass dressing percentage, external and internal carcass lengths, leg length and circumference, rump circumference and width, chest width and depth, full bodyweight, empty bodyweight, cooling losses, pH before and after cooling, loin, and leg. Silages of old man saltbush, buffelgrass, gliricidia and pornunça are recommended for inclusion in lamb diets. Diets with old man saltbush silage provide the best results for characteristics of the carcass and of non-carcass components besides weight gain, which can reach up to 200 g/day depending on the formulation.Keywords: Carcass composition, feedlot, saltbush, shee

A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis

Background: LiHyV is an antigenic hypothetical protein present in both promastigote and amastigote stages of Leishmania infantum, which was recently identified by an immunoproteomic approach. A recombinant version of this protein (rLiHyV) was evaluated as a diagnostic marker for canine VL (CVL). In addition, the prophylactic efficacy of the rLiHyV protein, and two of its CD8+ T cell epitopes, has been analyzed in a murine model of visceral leishmaniasis (VL). Methods: Initially, the rLiHyV protein was evaluated by an ELISA technique for the serodiagnosis of CVL. Secondly, vaccines composed of the recombinant protein and both chemically synthesized peptides, combined with saponin as an adjuvant; were administered subcutaneously into BALB/c mice. The cellular and humoral responses generated by vaccination were evaluated. In addition, the parasite burden and immune response were studied 10 weeks after L. infantum infection. Results: The rLiHyV protein was recognized by antibodies of VL dogs. No cross-reactivity was obtained with sera from dogs vaccinated with a Brazilian commercial vaccine, with sera from animals infected with Trypanosoma cruzi, Babesia canis and Ehrlichia canis, or those from non-infected animals living in an endemic area for leishmaniasis. After challenge with L. infantum, spleen cells of BALB/c mice vaccinated with rLiHyV/saponin stimulated with parasite antigens showed a higher production of IFN-γ, IL-12 and GM-CSF, than the same cells obtained from mice vaccinated with the individual peptides, or mice from control (inoculated with saline or saponin) groups. This Th1-type cellular response observed in rLiHyV/saponin vaccinated mice was accompanied by the induction of parasite-specific IgG2a isotype antibodies. Animals immunized with rLiHyV/saponin showed significant reductions in the parasite burden in the liver, spleen, bone marrow and in the lymph nodes draining the paws relative to control mice. Conclusions: The present study showed for the first time that the L. infantum LiHyV protein could be considered as a vaccine candidate against L. infantum infection, as well as a diagnostic marker for CVLThis work was supported by grants from Instituto Nacional de Ciência e Tecnologia em Nanobiofarmacêutica (INCT-Nanobiofar), FAPEMIG (CBB-APQ-00819-12), and CNPq (APQ-472090/2011-9, RHAE-456287/2012-4, APQ-482976/2012-8, and APQ-488237/2013-0). MACF is a grant recipient of FAPEMIG/CAPES. EAFC and APF are grant recipient of CNP

Large atom number dual-species magneto-optical trap for fermionic 6Li and 40K atoms

We present the design, implementation and characterization of a dual-species magneto-optical trap (MOT) for fermionic 6Li and 40K atoms with large atom numbers. The MOT simultaneously contains 5.2x10^9 6Li-atoms and 8.0x10^9 40K-atoms, which are continuously loaded by a Zeeman slower for 6Li and a 2D-MOT for 40K. The atom sources induce capture rates of 1.2x10^9 6Li-atoms/s and 1.4x10^9 40K-atoms/s. Trap losses due to light-induced interspecies collisions of ~65% were observed and could be minimized to ~10% by using low magnetic field gradients and low light powers in the repumping light of both atomic species. The described system represents the starting point for the production of a large-atom number quantum degenerate Fermi-Fermi mixture